Yuanli Chen
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Immune cells in cancer
Papers in
-
- Peroxisome Proliferator-Activated Receptors 26
- Surgery 45
- Cholesterol and Lipid Metabolism 31
- Co-authors
- Yajun Duan (95 shared papers)Xiaoxiao Yang (75 shared papers)Jihong Han (59 shared papers)Xiaoju Li (33 shared papers)Lun Wang (4 shared papers)Yongxin Li (4 shared papers)Yan Zhu (22 shared papers)Chuanrui Ma (23 shared papers)
- Journals
- Journal of Biological Chemistry (10 papers)Biochemical and Biophysical Research Communications (10 papers)Journal of Cardiovascular Pharmacology (6 papers)Biomedicine & Pharmacotherapy (6 papers)International Immunopharmacology (5 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Yuanli Chen
148 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 570
- Immunology 615
- Complementary and alternative medicine 227
- Electrochemistry 163
- Pharmacology 204
Countries citing papers authored by Yuanli Chen
This map shows the geographic impact of Yuanli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanli Chen more than expected).
Fields of papers citing papers by Yuanli Chen
This network shows the impact of papers produced by Yuanli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanli Chen. The network helps show where Yuanli Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuanli Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 225 | |
| 2 | 2018 | 163 | |
| 3 | 2020 | 121 | |
| 4 | 2019 | 115 | |
| 5 | 2021 | 115 | |
| 6 | 2020 | 108 | |
| 7 | 2015 | 101 | |
| 8 | Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. | 2016 | 82 |
| 9 | 2012 | 79 | |
| 10 | 2016 | 61 | |
| 11 | 2018 | 61 | |
| 12 | 2019 | 58 | |
| 13 | 2019 | 56 | |
| 14 | 2022 | 55 | |
| 15 | 2012 | 51 | |
| 16 | 2017 | 51 | |
| 17 | 2020 | 50 | |
| 18 | 2017 | 50 | |
| 19 | 2022 | 49 | |
| 20 | 2015 | 48 |
About Yuanli Chen
Yuanli Chen is a scholar working on Molecular Biology, Surgery, Cancer Research, Immunology and Oncology, having authored 155 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (31 papers), Peroxisome Proliferator-Activated Receptors (26 papers), Cancer, Lipids, and Metabolism (22 papers), Liver Disease Diagnosis and Treatment (15 papers), Drug Transport and Resistance Mechanisms (10 papers), Atherosclerosis and Cardiovascular Diseases (9 papers), Immune cells in cancer (7 papers) and interferon and immune responses (7 papers). The work is most often cited by research in Cancer Research (570 citations), Immunology (615 citations), Complementary and alternative medicine (227 citations), Electrochemistry (163 citations) and Pharmacology (204 citations). Yuanli Chen has collaborated with scholars based in China, United States and India. Frequent co-authors include Yajun Duan, Xiaoxiao Yang, Jihong Han, Xiaoju Li, Lun Wang, Yongxin Li, Yan Zhu, Chuanrui Ma, Xin Lv and Xue Huang. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Journal of Cardiovascular Pharmacology, Biomedicine & Pharmacotherapy and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.